检索

期
标题
作者
卷 30, 编号 4/5 (2023)
Pharmacotherapeutic aspects of gestational diabetes mellitus against the background of impaired maternal immunity
Kazimova A., Polukhova S.
PDF
(Rus)
卷 27, 编号 12 (2020)
Combination of two hypoglycemic drugs for type 2 diabetes mellitus
Morgunova T., Fadeyev V.
PDF
(Rus)
编号 5 (2015)
Preimushchestva fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysvobozhdeniya (Kombogliz Prolong) v terapii SD 2 tipa
Ametov A.
PDF
(Rus)
编号 5 (2013)
FARMAKOEKONOMIChESKIY ANALIZ PREIMUShchESTV KOMBINIROVANNOY INKRETINOVOY TERAPII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA NA PRIMERE VILDAGLIPTINA
Arinina E., Rashid M., Antsiferov M.
PDF
(Rus)
编号 5 (2011)
PATHOPHYSIOLOGICAL FEATURES OF TREATMENT OF ARTERIAL HYPERTENSION AND DISORDERS OF CARBOHYDRATE METABOLISM.
Shilov A., Osiya A., Dulaeva M., Eremina I., Shilov A., Osia A., Dulayeva M., Yeremina I.
编号 15 (2009)
Insulin resistance and heart diseases: is there a relationship?
Drapkina O., Smirin V., Ivashkin V., Drapkina O., Smirin V., Ivaschkin V.
卷 30, 编号 3 (2023)
Combination therapy for type 2 diabetes maintains its position. Clinical case
Podachina S., Biryukova E., Solovievа I.
PDF
(Rus)
卷 26, 编号 14 (2019)
Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance
Ametov A., Tertychnaya E.
PDF
(Rus)
编号 16 (2014)
Primenenie kombinirovannoy terapii glimepiridom i metforminom u patsientov s sakharnym diabetom 2 tipa. Rezul'taty Rossiyskogo observatsionnogo issledovaniya
Zaytseva N., Shamkhalova M.
PDF
(Rus)
编号 1 (2013)
METABOLIChESKIY SINDROM U DETEY: SOVREMENNYY VZGLYaD NA PROBLEMU
Zakharova I., Yablochkova S.
PDF
(Rus)
编号 3 (2011)
CLINICAL ASPECTS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: BENEFITS FOR DIFFERENT GROUPS OF PATIENTS
Antsiferov M., Antsiferov M.
编号 3 (2009)
Metformin - pathogenetic drug of first-line in the treatment of type 2 diabetes
Zilov A., Zilov A.
卷 29, 编号 11/12 (2022)
Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review
Petunina N., Martirosyan N., Valeeva F.
PDF
(Rus)
卷 26, 编号 14 (2019)
Start of therapy of type 2 diabetes mellitus with a fixed combination. Metformin with vildagliptin or glibenclamide, is there any difference?
Demidov N., Koteshkova O., Balberova M., Antsiferov M.
PDF
(Rus)
编号 16 (2014)
Fiksirovannaya kombinatsiya saksagliptina i metformina modifitsirovannogo vysvobozhdeniya - novyy shag v uluchshenii priverzhennosti k lecheniyu sakharnogo diabeta 2 tipa
Biryukova E.
PDF
(Rus)
编号 16 (2012)
Ratsional'naya farmakoterapiya SD 2 tipa: primenenie ingibitora DPP-4 saksagliptina i metformina v klinicheskoy praktike
Ametov A., Brashchenkova A.
PDF
(Rus)
编号 3 (2011)
COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N., Trukhina L., Petunina N., Truhina L.
编号 3 (2009)
Vildagliptin - a new dipeptidylpeptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
Antsiferov M., Dorofeeva L., Anciferov M., Dorofeeva L.
卷 29, 编号 11/12 (2022)
Clinical effects of dapagliflozin in patients with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Bagriy A., Prikolota O., Prikolota A., Mikhailichenko E., Golodnikov I., Bagriy O., Kotova K.
PDF
(Rus)
卷 26, 编号 4 (2019)
Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?
Biryukova E., Solovyova I.
PDF
(Rus)
编号 5 (2014)
METFORMIN - NADEZhNYY PARTNER V LEChENII PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA
Petunina N., Kuzina I.
PDF
(Rus)
编号 7 (2012)
DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M., Antsiferov M.
编号 16 (2010)
WHEN TO BEGIN COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N., Petunina N.
卷 31, 编号 2 (2024)
Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice
Elsukova O., Nikitina E., Chuprova A., Kaysina O.
PDF
(Rus)
卷 29, 编号 4 (2022)
Type 3 diabetes mellitus: is there a chance to become famous?
Morgunov L.
PDF
(Rus)
编号 4 (2018)
POSSIBILITIES OF METHORMINE IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS: TEST OF TIME
Biryukova E., Solovyeva I., Platonova N.
PDF
(Rus)
编号 5 (2014)
VLIYaNIE KOMBINATsII METFORMINA I VILDAGLIPTINA NA POKAZATELI UGLEVODNOGO I ZhIROVOGO OBMENOV U BOL'NYKh SAKhARNYM DIABETOM 2 TIPA
Abaeva M., Nazhmutdinova P., Ametov A.
PDF
(Rus)
编号 3 (2012)
SUSTAINED-RELEASE METFORMIN (GLUCOPHAGE LONG) IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Nikonova T., Nikonova T.
编号 16 (2010)
POTENTIALS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN TYPE 2 DIABETES MELLITUS: INITIATION AND CONTINUATION OF THERAPY
Antsiferov M., Zilov A., Antsiferov M., Zilov A.
卷 31, 编号 2 (2024)
Screening, diagnosis and treatment of early carbohydrate metabolism disorders
Demidova I., Boeva V.
PDF
(Rus)
卷 28, 编号 12 (2021)
Differentiated approach to metformin therapy in newly diagnosed type 2 diabetes mellitus from the perspective of pharmacogenetics
Shorokhova P., Baranov V.
PDF
(Rus)
编号 16 (2016)
Modern approaches to the treatment of patients with type 2 diabetes mellitus
Antsiferov M., Fadeev V., Morgunova T.
PDF
(Rus)
编号 16 (2013)
Preimushchestva novoy fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysbozhdeniya v terapii sakharnogo diabeta 2 tipa
Ametov A.
PDF
(Rus)
编号 3 (2012)
HOW TO EFFECTIVELY MANAGE TWO MAJOR DEFECTS IN TYPE 2 DIABETES MELLITUS?
Biryukova E., Antsiferov M., Biryukova Y., Antsiferov M.
编号 17 (2009)
SOVREMENNYE PODKhODY K LEChENIYu SAKhARNOGO DIABETA TIPA 2 U MUZhChIN
Tishova Y., Kalinichenko S.
卷 31, 编号 2 (2024)
Metformin prevents the development of atrial fibrillation
Leonova M.
PDF
(Rus)
卷 28, 编号 12 (2021)
Insulin resistance - a common enemy for endocrinologists and cardiologists
Verbovoy A., Dolgikh Y.
PDF
(Rus)
编号 5 (2016)
APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS
Antsiferov M.
PDF
(Rus)
编号 10 (2013)
Rannyaya diagnostika i lechenie narushennoy glikemii natoshchak zamedlyaet tempy ee konversii v narushennuyu tolerantnost' k glyukoze i sakharnyy diabet 2 tipa
Demidova I., Boeva V.
PDF
(Rus)
编号 16 (2011)
Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu
Antsiferov M., Antciferov M.
编号 17 (2009)
INNOVATsIONNYY KOMBINIROVANNYY PREPARAT GALVUS MET (VILDAGLIPTIN + METFORMIN) V LEChENII SAKhARNOGO DIABETA TIPA 2
Antsiferov M.
卷 30, 编号 12 (2023)
Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection
Zhurtova I., Gubachikova A., Aramisova L., Anaeva L., Abdul Moati H.
PDF
(Rus)
卷 27, 编号 12 (2020)
Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study
Mkrtumyan A., Vorobyev S., Volkova A., Vorokhobina N.
PDF
(Rus)
编号 17 (2015)
Gipoglikemiya i kachestvo zhizni bol'nykh sakharnym diabetom 2 tipa
Antsiferov M., Nikitina T., Rodionova A., Kurbatova K., Ionova T.
PDF
(Rus)
编号 5 (2013)
PREIMUShchESTVA METFORMINA PROLONGIROVANNOGO DEYSTVIYa
Petunina N., Trukhina L., Sinitsyna E., Antsiferov M.
PDF
(Rus)
编号 16 (2011)
DIPEPTIDYL PEPTIDASE-4 INHIBITORS - NEW POTENTIALS FOR TREATMENT OF TYPE 2 DIABETES MELLITUS: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M., Antciferov M.
编号 17 (2009)
MEKhANIZM DEYSTVIYa I KLINIChESKOE PRIMENENIE METFORMINA (SIOFOR®): OBZOR LITERATURY
Demidova I., Gorokhova T.
1 - 47 的 47 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语